REG - Hutchmed China Ltd - Announcement pursuant to AIM Rule 17 Schedule 2(g)London Stock Exchange·11 hours agoHCM+0.64%00013+1.59%
CICC Raises HUTCHMED TP to HKD26 on Bright Prospects for Overseas Filing of SavolitinibAASTOCKS News·12 hours agoHCM+0.64%00013+1.59%
HUTCHMED shares are trading higher after the company announced high-level results from the SAFFRON Phase III trial.benzinga_article·1 day ago, 07:35 AMHCM+0.64%00013+1.59%
HUTCHMED Announces ORPATHYS® Plus TAGRISSO® Demonstrated Statistically Significant and Clinically Meaningful Improvements in Progression-Free and Overall Survival in MET-Driven EGFR-Mutated Lung Cancer After Progression on TAGRISSO® | HCM Stock NewsStockTitan·2 days ago, 11:00 AMHCM+0.64%00013+1.59%
Huatai Securities Sticks to Their Buy Rating for HUTCHMED (China) (HCM)Tip Ranks·Aug 1 at 12:05 AMHCM+0.64%00013+1.59%
HUTCHMED 1H26 Net Profit USD15.928M, Down 96.5% YoYAASTOCKS News·Jul 30 at 08:41 PMHCM+0.64%00013+1.59%
HUTCHMED (China): Oncology sales surged over 40% in China, global launches expanded, and cash reserves remained strongQuartr·Jul 30 at 06:34 AMHCM+0.64%00013+1.59%
HUTCHMED H1 FY26 net income drops to USD 15.9 million; revenue rises 0.22% to USD 278.3 millionPUBT·Jul 30 at 06:10 AMHCM+0.64%00013+1.59%
Weekly Buzz: VRTX, APTX Gain FDA Nod; UNCY Disappoints; Ipsen Opens Wallet; VTGN Misses Goalrttnews·Jul 2 at 09:15 AMNVS+1.70%VRTX+2.45%
